The Barcelona Centre for International Health Research, CRESIB is a global health research institute developed from some of the leading academic and biomedical research institutions in Barcelona (Universitat de Barcelona, Hospital Clínic de Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) together with the Catalan Government as a response to the new international health challenges of the 21st century.
Pedro Alonso will rewiev the story of the RTS,S vaccine next Tuesday, February 7, on Cosmocaixa Barcelona. Dr. Alonso will reflect on the keys of the most significant breakthroughs achieved so far. After that, the Director of CRESIB will participate in an open forum of discussion [+]
The Lancet magazine publishes a study in which CRESIB researchers based in Papua New Guinea demonstrate the efficacy of a new oral treatment for yaws [+]
Pedro Alonso points out that the results published in 2011 are the product of more than a decade of work [+]
While welcoming this very positive news, CRESIB, one of the participants in this study, stresses the importance of continuing commitment and sustained action [+]
21-25 November, 2011 [+]
RTS,S is the most clinically advanced malaria vaccine candidate in the world. [+]
The largest clinical trial in children ever conducted in Africa [+]
Researchers call for research and developent funding to be maintained at a sustainable level despite the current financial crisis [+]
This edition's theme is "Global change, migration and health" [+]
As required in the 2012 call for AGAUR FI-DGR grants, CRESIB has established the criteria that the centre will use to prioritize the presented candidacies, which must also fulfill the requirements demanded by the call. [+]